MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

MMJ Recs

SEPTEMBER 19, 2023

In this article, we’ll explore the various chronic pain treatment options in Missouri, highlight top-rated pain specialists in the state, and delve into some of the specific services available, such as non-surgical pain relief in Missouri. Finding effective treatment is crucial to improving your quality of life.

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] More recently, MDMA therapy has inched closer to FDA approval. For the regulated community, this is a trend worth watching.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

FEBRUARY 21, 2024

Healthcare providers can offer guidance on potential benefits, risks, and interactions with existing treatments. Understanding the legal and regulatory landscape is essential to ensuring compliance and responsible use. Legal and Regulatory Considerations: The legal status of medical marijuana varies globally and within regions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

MMJ Recs

APRIL 25, 2024

Rigorous research and testing are conducted to assess the suitability of each strain for medical use, ensuring that patients receive optimal treatment outcomes. Testing Medical Cannabis for Quality Assurance: Testing medical cannabis is essential for ensuring product safety, potency, and compliance with regulatory standards.

Marijuana 52

Marijuana Cultivation Safety Trichome 52

Cannabis Law Report

JUNE 3, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

MMJ Recs

OCTOBER 9, 2023

Pain management in Texas has evolved significantly in recent years with the emergence of MMJ as a viable treatment option. As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively. Photo by Pixabay.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 98

Pets Medicine Treatment Conditions 98

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 95

Pets Medicine Treatment Conditions 95

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

United Patients Group

OCTOBER 25, 2023

Navigating the complex world of medical marijuana can be challenging, particularly for individuals who are new to this alternative form of therapy. Patients using medical marijuana must familiarize themselves with their state’s specific regulations and guidelines to ensure they are in compliance with the law.

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Cannabis Law Report

MARCH 1, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JULY 24, 2021

Ahmad Doroudian, Chief Executive Officer of BetterLife, stated: “TD-010 is a potential novel therapy to treat debilitating anxiety disorders that show resistance to benzodiazepine and other therapies or require a long-term use and therefore put patients at risk for dependency. Benzodiazepine Dependency. neuroscience. About Mitacs.

Research and Development 98

Research and Development Treatment Therapy Media 98

Cannabis Law Report

OCTOBER 2, 2021

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

MARCH 29, 2022

We are thrilled to have Michael’s expertise guiding the development of MDMA-assisted therapy for PTSD! Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

AUGUST 3, 2022

The lack of robust research on cannabis products, cannabis as a therapy and dependence or addiction to cannabis heightens the challenge of developing sound policies on the use of cannabis in health care facilities. Food and Drug Administration. Self-administration is prohibited. 1 See [link] and [link]. 2 [link]. 3 [link].

Research and Development 98

Research and Development Policy Patients Compliance 98

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. Attorney Charles Feldmann has worked extensively with a variety of state agencies focused on enforcement, licensing, federal risk mitigation, and compliance.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

JUNE 24, 2021

Luxembourg decrimininalised the sale and prescription of medicinal cannabis for the treatment of chronic pain, cancer, neuro-degenerative, and other chronic diseases starting August 2018, with approved products sold out of the country’s hospital pharmacies. Complementary therapy. PARLIAMENTARY QUESTION. Surge in demand.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. InnarisBio aims to be a revolutionary technology company for intranasal drug delivery in the treatment of CNS disorders. A potential solution is direct nose-to-brain delivery. About atai Life Sciences.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Law Report

MAY 31, 2022

Two approaches apply to commercial operations—the traditional medical path and the emerging non-medical state-regulated path, while the other two paths are better seen as non-commercial—underground therapy and religious use. Breakthrough Therapy status obtained by COMPASS Pathways and Usona Institute. Breakthrough Therapy.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

JANUARY 12, 2022

The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. Following the required transfer of Gb Sciences’ cannabis production and extraction licenses to AJE Management, LLC by the Nevada Cannabis Compliance Board on Dec. 31, 2021.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

NORML

FEBRUARY 22, 2019

Senate Bill 1003 / House Bill 2273 to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. Legislation is pending, Senate Bill 8, as well as Senate Bill 598, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations.

Legislation 176

Legislation Hemp Compliance Compliance 176

MMJ Recs

MARCH 2, 2024

Observing discretion in discussions regarding medical conditions and treatment enhances privacy and respect among patrons. Ohio Cannabis Dispensary Regulations Dispensaries must adhere to strict regulations set forth by the Ohio Medical Marijuana Control Program to ensure compliance and patient safety.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

AUGUST 17, 2021

Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Medical Imaging Software Improves Diagnostic Accuracy and Supports Doctors in Designing Better Treatment for Patients. The Strategic Imperative.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

AUGUST 20, 2021

In an opinion piece published in The Times today , Conservative MP Dan Poulter, a practising NHS doctor, wrote that the drug has a lot of medical benefits – including the treatment of chronic pain, reduction of nausea for patients undergoing chemotherapy, and as a therapy for poor sleep and anxiety disorders.

Policy 105

Policy Chronic Pain Medicine Therapy 105

Cannabis Law Report

DECEMBER 9, 2021

MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. NEW YORK , Dec. 9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. MindMed is also traded in Germany under the symbol MMQ.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

AUGUST 19, 2021

Through the introduction of new cultivars, Cantourage and Cannim are providing new treatment options for patients in Europe. Our partnership with Cantourage allows us to introduce our products to the European market and provide new therapy options for patients”.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JANUARY 14, 2022

Unapproved medications such as cannabis in Germany can only be approved on the basis of three criteria: (1) When it is for the treatment of a serious (life-threatening or permanently detrimental to the quality of life) medical condition; (2) Where no other therapy is available; and. (3)

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

OCTOBER 8, 2021

Normally, if a patient exhibits two or more seizures, he is initiated on antiepileptic drug (AED) treatment. Despite the availability of over 20 antiepileptic drugs for the symptomatic treatment of epileptic seizures, about one third of patients with epilepsy have seizures refractory to pharmacotherapy ”.

Epilepsy 52

Epilepsy Chronic Pain Patients Treatment 52

PrestoDoctor

AUGUST 2, 2023

In the state of Iowa, obtaining a medical cannabis card is a pathway towards accessing this alternative form of treatment legally and safely. One of the key advantages of medical cannabis is its potential to offer a natural and alternative option for patients who have not found relief through traditional medications or therapies.

Conditions 52

Conditions Epilepsy Dispensary Patients 52

NORML

FEBRUARY 8, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. CO resident? Connecticut. NORML opposes this legislation.

Legislation 172

Legislation Decriminalization Patients Access 172

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81